Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
4.000
-0.010 (-0.25%)
Apr 22, 2026, 11:29 AM CST
SHA:603718 Market Cap
SHA:603718 has a market cap or net worth of 2.61 billion as of April 21, 2026. Its market cap has decreased by -41.22% in one year.
Market Cap
2.61B
Enterprise Value
2.33B
Revenue
246.35M
Ranking
n/a
PE Ratio
15.12
Stock Price
4.00
Market Cap Chart
Since May 15, 2015, SHA:603718's market cap has decreased from 2.75B to 2.61B, a decrease of -4.83%. That is a compound annual growth rate of -0.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.61B | -34.64% |
| Dec 31, 2025 | 4.00B | -12.02% |
| Dec 31, 2024 | 4.55B | -35.48% |
| Dec 29, 2023 | 7.05B | 11.42% |
| Dec 30, 2022 | 6.32B | -35.82% |
| Dec 31, 2021 | 9.85B | 21.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Sihuan Bioengineering | 3.08B |
| Guangdong VTR Bio-Tech | 2.97B |
| Suzhou Fushilai Pharmaceutical | 2.88B |
| Shandong Sito Bio-technology | 2.62B |
| Shanghai Universal Biotech | 2.61B |
| Jilin Jian Yisheng Pharmaceutical | 2.54B |
| Hubei Goto Biopharm | 2.51B |
| Zhejiang East Asia Pharmaceutical | 2.30B |